Journal for ImmunoTherapy of Cancer (Nov 2021)

499 A first-in-human, phase 1/2 clinical trial of TK-8001, a MAGE-A1 directed T cell receptor in patients with advanced-stage solid tumors (The “IMAG1NE”-trial)

  • Fiona Thistlethwaite,
  • Sylvie Rottey,
  • Emiliano Calvo,
  • Antonia Busse,
  • Martin Wermke,
  • Ralf Wolter,
  • Thomas Blankenstein,
  • Vivian Scheuplein,
  • Elisa Kieback,
  • Matthias Obenaus,
  • Eugen Leo,
  • Ioannis Gavvovidis,
  • Marie-Luise Goebeler,
  • Nuria Kotecki,
  • Carolina Perdomo-Ortiz

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.499
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.